0183 Progranulin (PC-derived growth factor) levels in serum do not predict response to neoadjuvant capecitabine (X), docetaxel (T) and trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC)

✍ Scribed by H. Wildiers; I. Buysschaert; A. Van Hootegem; A. Smeets; I. Vanden Bempt; P. Neven; P. Moerman; P. Schöffski; R. Paridaens; D. Lambrechts

• Book ID: 114316312
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 63 KB
• Volume: 18
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(09)70206-1